Last 632.80 INR
Change Today +1.75 / 0.28%
Volume 41.9K
PIEL On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for piramal enterprises ltd (PIEL)

Year over year, Piramal Enterprises Limited has seen their bottom line shrink from a loss of 2.3B INR to an even larger loss of 5.0B INR despite an increase in revenues from 35.2B INR to 45.0B INR. An increase in the percentage of sales devoted to SGA costs from 38.11% to 41.27% was a key component in the falling bottom line in the face of rising revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2011
Restated
INR
Mar 31
2012
Restated
INR
Mar 31
2013
Restated
INR
Mar 31
2014
INR
4 Year
Trend
Revenues16,730.821,588.735,201.944,959.4
Other Revenues0.44.7----
TOTAL REVENUES20,056.323,502.335,443.345,201.6
Cost of Goods Sold8,287.010,775.313,478.515,003.5
GROSS PROFIT11,769.312,727.021,964.830,198.1
Selling General & Admin Expenses, Total7,028.07,331.113,414.018,555.2
R&D Expenses710.92,331.32,867.22,956.8
Depreciation & Amortization, Total958.61,292.92,095.62,465.9
Other Operating Expenses847.1818.4774.31,414.3
OTHER OPERATING EXPENSES, TOTAL9,544.611,773.719,151.125,392.2
OPERATING INCOME2,224.7953.32,813.74,805.9
Interest Expense-879.5-1,009.4-4,830.1-8,715.9
NET INTEREST EXPENSE-879.5-1,009.4-4,830.1-8,715.9
Income (Loss) on Equity Investments-----42.3-31.3
Currency Exchange Gains (Loss)986.02,787.41,548.01,984.9
Other Non-Operating Income (Expenses)-124.4-1,396.3-1,232.2-554.9
EBT, EXCLUDING UNUSUAL ITEMS2,206.81,335.0-1,742.9-2,511.3
Merger & Restructuring Charges-496.2-56.6-191.3-166.3
Gain (Loss) on Sale of Investments-------9.6
Gain (Loss) on Sale of Assets-0.9---22.7-85.6
Other Unusual Items, Total162,435.8-69.5-12.6-1,606.2
Other Unusual Items162,701.2---12.5-1,606.2
EBT, INCLUDING UNUSUAL ITEMS164,145.51,208.9-1,969.5-4,379.0
Income Tax Expense36,789.056.3247.6627.5
Minority Interest in Earnings-3.1-37.6-55.8-7.6
Earnings from Continuing Operations127,356.51,152.6-2,217.1-5,006.5
EARNINGS FROM DISCOUNTINUED OPERATIONS1,480.2------
NET INCOME128,833.61,115.0-2,272.9-5,014.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS128,833.61,115.0-2,272.9-5,014.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS127,353.41,115.0-2,272.9-5,014.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PIEL:IN 632.80 INR +1.75

PIEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biocon Ltd 513.15 INR -4.35
Divi's Laboratories Ltd 1,479 INR +0.65
Jubilant Life Sciences Ltd 193.45 INR -1.20
Sanofi India Ltd 2,943 INR -19.00
Torrent Pharmaceuticals Ltd 699.75 INR +2.80
View Industry Companies
 

Industry Analysis

PIEL

Industry Average

Valuation PIEL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 1.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PIRAMAL ENTERPRISES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.